AI in Healthcare

The week in medical AI, judged by one question: does this actually change what we do for patients? Saturday 27 June 2026.

• Diagnostic AI: EchoNext, among the first multi-condition cardiology AIs cleared by the FDA (23 June), reads a standard 12-lead ECG to flag six forms of structural heart disease. In its Nature validation it caught 77% of structural heart problems versus 64% for 13 cardiologists reading the same 3,200 ECGs, but it triages, it does not diagnose, and the echo still decides.
• Ambient AI, a reality check: in 263 clinicians across six health systems (JAMA Network Open), burnout fell from 51.9% to 38.8% in 30 days, yet time savings are modest on average and concentrate in heavy users, while the value shifts into the revenue cycle.
• The skeptic's corner: a new Nature paper shows medical-AI models can leak whether an individual patient was in the training data almost perfectly, even when aggregate privacy metrics look safe, and underrepresented patients are the easiest to single out.
• From the literature, via PubMed: two big meta-analyses on AI reading scans (breast nodal status, AUC 0.84; rectal complete response, AUC 0.85) with likelihood ratios that say adjunct, not replacement.
• Follow the money: once Medicare paid for AI to detect large-vessel strokes (NTAP), billed use reached about 21% by 2022, but adoption tracked the hospital, not the patient, an equity problem (AJNR).
• Teaching point: compared with what? Four questions before any tool changes a decision.

A new episode every Saturday. Subscribe, rate the show, and send your feedback.

Sources & further reading: Nature; Nature (privacy audit); European Radiology; Molecular Imaging; American Journal of Neuroradiology; JAMA Network Open; FDA; NewYork-Presbyterian / Columbia; PubMed and the National Library of Medicine.

The week's most important developments in medical AI, and the one question that matters: does this actually change what we do for patients? Saturday, 20 June 2026.

In this episode:

• Diagnostic AI. Hetairos predicts 102 methylation-defined CNS tumour subtypes from a routine H&E slide. Built and validated on 9,606 patients and 11,000+ slides across 11 centres on 4 continents; from histology alone it scored 0.87 on confident calls, and 0.68 versus 0.30 for five board-certified neuropathologists, turning a roughly 12-day molecular workup into about 12 minutes. Why molecular testing still rules, and where this really changes access.

• Ambient AI grows up. Abridge expands beyond the scribe into coding, prior authorisation, claims and decision support, backed by a strategic Eli Lilly investment. Philips' Future Health Index 2026: 46% of clinicians save at least 132 hours a year, half report capacity for about 8 more patients a week, and 65% increased their AI use at work.

• The skeptic's corner. Overtrust in AI medical advice, how the way you prompt can steer a model toward more accurate but also more harmful answers, and the habit that protects you: compared with what?

• From the literature, via PubMed. The AMIE RCT in Nature Medicine (assisted care preferred 47% vs 33%, fewer clinically significant errors 13% vs 24%), a 70-clinician RCT in npj Digital Medicine, plus the PROTEUS AI stress-echo trial.

• Follow the money. CPT 2026 adds 288 new codes including AI services (live since 1 January), NHS England commits £20m to scale AI chest X-ray, the US HHS issues an RFI on AI to cut costs, and the WHO publishes a discussion paper on AI in health policy.

• The teaching point. A performance metric is a signal, not proof of benefit. A number is a signal, not a target.

A new episode every Saturday. Subscribe, rate the show, and send your feedback.

Sources & further reading: Nature Cancer (Hetairos); Digital Health News and Philips Future Health Index 2026; NEJM AI and Lancet Digital Health; Nature Medicine and npj Digital Medicine (via PubMed / National Library of Medicine); AMA CPT 2026; NHS England; US HHS; WHO.

This week’s AI in Healthcare update covers four key developments: an NEJM AI randomized trial finding AI literacy training did not prevent automation bias from intentionally erroneous LLM diagnostic suggestions; FDA clearance and a CMS reimbursement pathway for Bunkerhill’s AI tools quantifying coronary and aortic valve calcium on routine contrast, non-gated chest CT (with limited independent peer-reviewed validation noted); a 48-trial Bayesian network meta-analysis (34,106 participants) reporting five AI colonoscopy systems improved adenoma detection rate but not advanced adenomas or sessile serrated lesions; and a Nature Medicine perspective urging higher evidentiary standards and patient-centered outcomes before claiming AI improves healthcare.

00:00 Weekly AI Healthcare Briefing

00:48 AI Literacy vs Automation Bias

02:22 FDA Cleared Calcium Detection

03:55 AI Colonoscopy Meta Analysis

05:54 Raising the Evidence Bar

07:23 Wrap Up and Next Week

In this week's episode of AI in Healthcare, your concise update for healthcare professionals on artificial intelligence in clinical medicine, we examine four developments from the week of April 20–27, 2026.

A New England Journal of Medicine Perspective on Utah's AI-assisted prescription-renewal sandbox pilot — a state-regulated program with pharmacist-mediated escalation, distinct from the FDA pathway for software as a medical device — and the corresponding American Hospital Association governance panel on April 20.

A multicenter Korean validation study in JMIR Medical Informatics introducing patient-wise recalibration to mitigate model drift in AI electrocardiography for left ventricular systolic dysfunction (reported AUC 0.956 internal, 0.940 external on follow-up pairs).

A randomized controlled trial in JMIR Mental Health in which both a structured generative AI therapy chatbot and plain GPT-4o produced significant PHQ-9 reductions versus control, with no significant difference between active arms (n = 147).

A methodological comparison in JMIR in which XGBoost (micro-F1 0.815) outperformed a LoRA-fine-tuned LLaMA-3 (0.780) on ASA Physical Status classification.

Evidence-based, reference-linked, ~5 minutes. For healthcare professionals only.

00:00 Weekly Headlines

00:31 Utah Prescribing Sandbox

02:09 Governance Takeaways

02:38 Drift Mitigation Study

04:06 GenAI Depression Trial

05:35 LLM vs XGBoost Methods

06:48 Wrap Up and References

REFERENCES

1. Utah Prescription-Renewal Pilot. NEJM Perspective, April 2026. DOI: 10.1056/NEJMp2601148
2. Utah Department of Commerce / Doctronic announcement, January 2026: commerce.utah.gov
3. AHA Panel — AI in Health Care: Navigating Policy, Regulation, and the Road Ahead. April 20, 2026: aha.org
4. Lee S, Son J-W, Kim S-A, et al. Deep Learning Model Using Transfer Learning for Detecting Left Ventricular Systolic Dysfunction. JMIR Med Inform. April 24, 2026. DOI: 10.2196/83127
5. Kuta B, Novak L, Zidkova R, et al. Effectiveness of a Fully Automated Mobile Therapeutic Versus a General Chatbot in Reducing Depression and Anxiety. JMIR Ment Health. April 22, 2026. DOI: 10.2196/82642
6. Chen M-C, Ruan S-J, Wu J-H, Chen P-F. Classifying ASA Physical Status With a Low-Rank-Adapted Large Language Model. J Med Internet Res. April 21, 2026. DOI: 10.2196/89540

 Disclaimer: For healthcare professionals only. Not medical advice. Opinions expressed do not represent any institution.

#AIinHealthcare #ClinicalAI #DigitalHealth #FDA #AIRegulation #AIECG #GenerativeAI #LLM #NEJM #JMIR

This episode of the AI in Healthcare Podcast explores how machine learning can strengthen everyday cardiovascular assessment without overhauling clinical workflows. Drawing on findings from the SCOT‑HEART trial, it highlights a gradient‑boosted model trained on 1,769 patients using routine clinic variables: age, sex, cholesterol, risk score, ECG, and exercise testing, to predict CAD on coronary CT angiography with an AUC of 0.80, surpassing traditional risk scores. The discussion focuses on what this means for triaging chest‑pain referrals, prioritizing imaging resources, and starting preventive therapy earlier—all while emphasizing that imaging remains essential for plaque characterization and that real‑world validation is critical before implementation.

Rainey, A., Williams, M., Berry, C., Dweck, M. R., Williams, M. C., & SCOT‑HEART ISCOT-HEARTrs. (202this study. Machine learning to predict high‑risk coronarSCOT-HEARTisease othis studycomputed tomoggradient-boostedT‑HEART trial. BMJ Open Heart, 12(2), e003162. https://doi.org/, including0.1136/openhrt‑2025‑003162

In this episode of the AI in Healthcare podcast, we explore new research on using gradient-boosted models to predict coronary artery disease. 

00:00 Introduction to AI in Healthcare Podcast

00:09 Gradient-Boosted Models in Coronary Artery Disease Prediction

00:47 Improving Referral Pathways with Transparent Models

01:18 Pragmatic Steps for Clinical Implementation

01:40 Key Takeaways and Recommendations

01:55 Conclusion

Williams MC, Guimaraes ARM, Jiang M, Kwieciński J, Weir-McCall JR, Adamson PD, et al. Machine learning to predict high-risk coronary artery disease on CT in the SCOT-HEART trial. Open Heart. 2025 Sep 1;12(2):e003162. doi:10.1136/openhrt-2025-003162. PMCID: PMC12406813. PMID: 40889953.  

In this episode of the AI in Healthcare podcast, we break down a new study by Jeong and colleagues that explores the impact of AI assistance on radiologist reading times and workflow efficiency.

One‑line takeaway: AI assistance reduced reading time and improved throughput for bone‑age radiograph interpretation in a real‑world retrospective cohort.

Reference

The Impact of Artificial Intelligence on Radiologists’ Reading Time in Bone Age Radiograph Assessment Citation: Jeong S, Han K, Kang Y, et al. Journal of Imaging Informatics in Medicine. 2025 Aug;38(4):1915‑1923.

https://pubmed.ncbi.nlm.nih.gov/39528879/

Join us on the AI in Healthcare podcast as we discuss into the groundbreaking development of VentAI, a reinforcement learning algorithm designed to recommend optimal ventilator settings for ICU patients.

00:00 Introduction to AI in Healthcare

00:06 VentAI: Revolutionizing Ventilator Settings

00:20 Study and Validation of VentAI

00:54 Performance and Comparison with Clinician Care

01:37 The Role of AI in Clinical Decision Making

01:56 Future of AI in Intensive Care

02:02 Conclusion and Follow Us